Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-26-018231
Filing Date
2026-02-19
Accepted
2026-02-19 11:16:52
Documents
106
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0276826-10k_biomxinc.htm   iXBRL 10-K 1634997
2 COMPOSITE COPY OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPA ea027682601ex3-1_biomxinc.htm EX-3.1 36763
3 COMPOSITE COPY OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPA ea027682601ex3-2_biomxinc.htm EX-3.2 37353
4 DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EX ea027682601ex4-1_biomxinc.htm EX-4.1 25492
5 FORM OF INDEMNIFICATION AGREEMENT ea027682601ex10-3_biomxinc.htm EX-10.3 75057
6 SUBSIDIARIES OF COMPANY ea027682601ex21-1_biomxinc.htm EX-21.1 1454
7 CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.), A MEMBER ea027682601ex23-1_biomxinc.htm EX-23.1 3676
8 CERTIFICATION ea027682601ex31-1_biomxinc.htm EX-31.1 9619
9 CERTIFICATION ea027682601ex31-2_biomxinc.htm EX-31.2 9444
10 CERTIFICATION ea027682601ex32-1_biomxinc.htm EX-32.1 4710
  Complete submission text file 0001213900-26-018231.txt   9219020

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE phge-20251231.xsd EX-101.SCH 85466
12 XBRL CALCULATION FILE phge-20251231_cal.xml EX-101.CAL 80995
13 XBRL DEFINITION FILE phge-20251231_def.xml EX-101.DEF 431712
14 XBRL LABEL FILE phge-20251231_lab.xml EX-101.LAB 771006
15 XBRL PRESENTATION FILE phge-20251231_pre.xml EX-101.PRE 456054
109 EXTRACTED XBRL INSTANCE DOCUMENT ea0276826-10k_biomxinc_htm.xml XML 970201
Mailing Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904
Business Address 850 NEW BURTON ROAD SUITE 201 DOVER DE 19904 972 545610935
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38762 | Film No.: 26652541
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)